700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Original Articles Open Access
African trypanosomiasis remains a life-threatening disease and there is nowadays an urgent need for improved therapeutic agents for this pathology. In this context, in order to create novel anti-protozoa prototype containing both a trypanocidal thiosemicarbazide moiety and an immuno-potentiating thalidomide-like, a hybrid structure was designed on the basis of a convergent synthesis process, synthesized and assayed for its potential trypanocidal activity. Initial biological results are very promising. The structure of the target compound was ascertained on the basis of 13C-NMR, IR spectroscopy and semi-empirical AM1/PM3 quantum-mechanical calculations.
To read the full article Peer-reviewed Article PDF
Author(s): Urbain C Kasshin Fernand A Gbaguidi Christopher R McCurdy and Jacques H Poupaert
Trypanocidal activity, immunostimulating thalidomide, thioacyl-thiosemicarbazide, thiosemicarbazide pharmacophore, Schotten-Baumann thioacylation reaction., thiosemicarbazide